{"inputs":{"TA":-137.0,"CA":23006.0,"CL":22869.0,"TL":-274.0,"EQ":137.0,"EBIT":136.0},"accounts_type":"","status":"Active","sic":"82990","as_of":"2026-10-22","ratios":{"working_capital":-1.0,"leverage":-0.5,"equity_cushion":-1.0},"z":{},"company_number":"16303746","name":"JBEL PHARMA CONSULTING LIMITED","score":10,"band":"distress","layer":"A","confidence":"medium","bs_date":"2026-03-31"}